Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04643548
Other study ID # NeuroCovid-RNI 2020 GODET
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 13, 2020
Est. completion date August 13, 2021

Study information

Verified date November 2020
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone +33 4 754 963
Email llaclautre_perrier@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The SARS-CoV-2 epidemic is leading to a large number of patients in intensive care units due to severe hypoxemic pneumonia. After an acute phase that may require controlled mechanical ventilation and deep sedation, removal of sedation often reveals a pathological awakening in the vast majority of patients. This encephalopathy state remains, to date and to our knowledge, unexplained. Clinical features do not appear to fully correlate with regular delirium. This encephalopathy might be explained by deep and prolonged hypoxemia, a wide use of sedation drugs, systemic inflammation or the hostile ICU environment.


Description:

This study is intended to investigate neurological abnormalities associated with SARS-CoV-2 infection. Complete daily neurological examinations will be routinely conducted in intensive care unit patients. Specific biological analyses will also be performed in these patients by collecting additional blood samples from an arterial or central catheter, every 2 days. These clinical and biological examinations will be continued throughout patient's stay in the intensive care unit.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date August 13, 2021
Est. primary completion date June 13, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years old - COVID-19 positive patient (positive RT PCR, nasopharyngeal or tracheal) - Patient admitted in an intensive care unit of the department of Anesthesia, Critical Care and Perioperative of Clermont-Ferrand University Hospital - Patient with an arterial or central catheter to perform blood samples collection Exclusion Criteria: - Patient or family member's refusal to participate - Neuropsychiatric history that may interfere with neurological evaluations in the intensive care unit - Patient not affiliated with French social security insurance - Patient under legal guardianship

Study Design


Locations

Country Name City State
France CHU Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dosage of biomarkers typically explored in intensive care unit delirium Plasminogen activator inhibitor-1 (PAI-1), E-selectin and angiopoietin-2 Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every 2 days
Primary Dosage of neuronal injury markers S100 ß, Neuron Specific Enolase (NSE), GFAP, UCHL1, NFL Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every 2 days
Secondary Delirium assessment CAM-ICU (Confusion Assessment Method - Intensive Care Unit) scale Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Delirium assessment ICDSC (Intensive Care Delirium Screening Checklist) scale. Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Coma assessment CRS-R (Coma Recovery Scale-Revised) Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Pupils characteristics Clinical observation Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Pupils characteristics Pupilometer assessment Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Neurological abnormalities Electroencephalogram : epileptic activity (spikes, spike-waves) or encephalopathy activity (triphasic waves)) Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Neurological abnormalities CT-scan Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
Secondary Neurological abnormalities MRI Change from Day 0 (= First day in ICU) until the end of the stay (up to 3 months) - Assessments every days
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A